ZBH — Zimmer Biomet Holdings Income Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual income statement for Zimmer Biomet Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	6,128	6,827	6,940	7,394	7,679
Cost of Revenue
Gross Profit	4,303	4,867	4,920	5,310	5,487
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	6,044	6,132	6,244	6,117	6,393
Operating Profit	83.1	695	696	1,278	1,286
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-105	499	404	1,067	1,037
Provision for Income Taxes
Net Income After Taxes	-9.2	446	291	1,025	905
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-139	402	231	1,024	904
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-139	402	231	1,024	904
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	2.06	3.66	3.2	5.78	5.6
Dividends per Share